Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07519031) titled 'Study of Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in Vitiligo' on April 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Xijing Hospital
Condition:
Vitiligo
Mesenchymal Stem Cells
Exosomes
Intervention:
Biological: Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes (hUC-MSC-Exos) Intravenous Infusion
Drug: Oral Prednisone
Biological: Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes (hUC-MSC-Exos) Local Injection
Drug: Topical Tacrolimus Ointment
...